Program

Course overview

This training course aims at promoting an integrated technology in carbon-ion radiotherapy, providing basic knowledge and practice-oriented trainings concerning carbon-ion radiotherapy as well as other topics related to this field.

Target Group

This training course is targeted primarily at participants with some expertise in radiotherapy and those who are interested in carbon-ion radiotherapy. Not only that, but also, trainees in radiotherapy, radiation oncologists, medical physicists, radiation biologists, radiological technologists, and any individuals having interests in this field.

Program

Introduction

History of CIRT
Hirohiko Tsujii
QST *
J-CROS activities
Hiroshi Tsuji
QST *
Cost effectiveness of CIRT
Tatsuya Ohno
Gunma University

Biology

Characteristics of Carbon ion Radiotherapy in cancer therapy
Marco Durante
GSI Helmholtzzentrum für Schwerionenforschung
Role of heavy-ion-induced free radicals
Ryoichi Hirayama
QST *
Harnessing heavy ions to improve immunotherapy
Takashi Shimokawa
QST *
Rationale for hypofractionation
Yukari Yoshida
Gunma University
DNA damage and cell killing effects by high-LET particle beams
Atsushi Shibata
Gunma University
Immune Radiotherapy
Noriyuki Okonogi
QST *
Targeted Radionuclide Therapy
Sumitaka Hasegawa
QST *
FLASH Particle Therapy
Taku Inaniwa
QST *

Physics

Accelerators for CiRT inc. Quantum Scalpel
Toshiyuki Shirai
QST *
Beam delivery, QA and Radiation protection
Shunsuke Yonai
QST *
Biological models for CIRT
Naruhiro Matsufuji
QST *
Treatment planning and Range uncertainty in CIRT
Nobuyuki Kanematsu
QST *
Motion management
Hideyuki Mizuno
QST *
IGRT with in-room CT
Makoto Sakai
Gunma University
Facility design of Yonsei Cancer Center Korea
Jin Sung Kim
Yonsei Cancer Center
Facility commissioning at Osaka
Masaaki Takashina
OSAKA HIMAK
Facility commissioning at Yamagata
Hikaru Souda
Yamagata University
What Particle Therapy Can Learn from IMRT and Other High- Precision Radiotherapies
Arnold Pompos
UTSouthwestern Medical Center

Clinical aspects

Head & Neck
(including Skull base &Lacrimal gland)
Masashi Koto
QST *
Eye
Masaru Wakatsuki
QST *
Lung
Mio Nakajima
QST *
Liver
Kei Shibuya
Gunma University
Pancreas
Makoto Shinoto
QST *
Bone & Soft tissue Sarcoma
Reiko Imai
QST *
Genitourinary tumors (prostate, kidney)
Hitoshi Ishikawa
QST *
Locally recurrent Rectal cancer
Hirotoshi Takiyama
QST *
Gynecological
Kazutoshi Murata
QST *
Breast
Yasumasa Mori
QST *

Diagnosis

Molecular diagnosis for radiotherapy
Ryuichi Nishii
QST *
Diagnostic imaging for radiotherapy
Riwa Kishimoto
QST *

Topics

Overview of Proton Therapy
Hideyuki Sakurai
Tsukuba University
Rationale and Indications for CIRT at Mayo Clinic USA
Robert L. Foote
Mayo Clinic
Overview of BNCT
Yoshihiro Takai
Southern Tohoku BNCT Research Center
Radiation Emergency Medicine
Hideo Tatsuzaki
QST *

Vendor presentation

  • Toshiba Corporation
  • Hitachi, Ltd.
  • Sumitomo Heavy Industries
  • RaySearch Laboratories
  • B dot Medical Inc.

Introduction of facilities

  • QST *
  • Gunma University Heavy Ion Medical Center
  • Kanagawa cancer center
  • Osaka Heavy Ion Therapy Center
  • Hyogo Ion Beam Medical Center
  • Saga Heavy ion Medical Accelerator in Tosu, SagaHIMAT
  • Yamagata University East Japan Heavy Ion Center

*) QST : National Institutes for Quantum and Radiological Science and Technology